Page last updated: 2024-10-26

doxepin and Atrophy

doxepin has been researched along with Atrophy in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borzecki, Z1
Woźniak, F1
Swies, Z1

Other Studies

1 other study available for doxepin and Atrophy

ArticleYear
Assessment of long-lasting effect of various doses of Sinequan on microstructure of the male gonad of the white rat.
    Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 1987, Volume: 42

    Topics: Animals; Atrophy; Dose-Response Relationship, Drug; Doxepin; Leydig Cells; Male; Rats; Seminiferous

1987